Short- and Long-Term Outcomes of Robot-Assisted Versus Video-Assisted Thoracoscopic Esophagectomy for Esophageal and Esophagogastric Junction Cancer
Authors:
- Eisuke BookaEBEisuke Booka
- Takahiro KurodaTKTakahiro Kuroda
- Shuhei YasumotoSYShuhei Yasumoto
- Keita MisuKMKeita Misu
- Yuki SakaiYSYuki Sakai
- Kenichi SekimoriKSKenichi Sekimori
- Shunta NakamuraSNShunta Nakamura
- Ryoma HanedaRHRyoma Haneda
- Wataru SonedaWSWataru Soneda
- Mayu SakataMSMayu Sakata
- Yoshifumi MoritaYMYoshifumi Morita
- Hirotoshi KikuchiHKHirotoshi Kikuchi
Open Access
Abstract
Background/Objectives: Thoracoscopic esophagectomy is an accepted minimally invasive approach for resectable esophageal and esophagogastric junction cancer in Japan. Whether robot-assisted minimally invasive esophagectomy (RAMIE) improves short- and long-term outcomes compared with video-assisted thoracoscopic esophagectomy (VATS) remains clinically relevant. Methods: We retrospectively reviewed patients who underwent VATS or RAMIE between January 2017 and April 2026. Patients who underwent open esophagectomy, non-gastric conduit reconstruction, or staged operation were excluded. Propensity score matching (PSM) was performed using age, sex, body mass index, histology, tumor location, clinical stage, preoperative therapy, extent of lymph node dissection, abdominal approach, and reconstruction route. Long-term outcomes were explored in a PSM cohort limited to patients treated between January 2017 and December 2023. Results: The main cohort included 369 patients (VATS, n = 186; RAMIE, n = 183). Overall complications of Clavien–Dindo (CD) grade ≥ II were comparable between VATS and RAMIE (32.8% vs. 32.8%, p = 0.999), whereas RLNP CD ≥ I (9.7% vs. 3.8%, p = 0.025) and RLNP CD ≥ II (3.8% vs. 0.5%, p = 0.034) were less frequent after RAMIE. PSM yielded 128 matched pairs; RLNP remained less frequent after RAMIE (CD ≥ I, 10.9% vs. 3.1%, p = 0.015; CD ≥ II, 4.7% vs. 0%, p = 0.013), while other short-term outcomes were comparable. In the survival PSM cohort (79 pairs), 3-year overall survival (66.0% vs. 73.4%, p = 0.203) and recurrence-free survival (62.3% vs. 59.3%, p = 0.651) did not differ significantly between VATS and RAMIE. Conclusions: RAMIE showed comparable short-term safety to VATS and was associated with lower RLNP after adjustment for clinicopathological, treatment-related, and surgical factors. Exploratory long-term analysis was limited by cohort size and follow-up duration but suggested that RAMIE did not compromise oncologic outcomes.Keywords
This publication has 26 references indexed in Scilit:
- Short-and middle-term outcomes of robot-assisted minimally invasive esophagectomy for highly locally advanced esophageal cancer with stage cT3 borderline and cT4b at initial diagnosisSurgical Endoscopy, 2025
- Japanese Classification of Esophageal Cancer, 12th Edition: Part IEsophagus, 2024
- Japanese Classification of Esophageal Cancer, 12th Edition: Part IIEsophagus, 2024
- Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2Esophagus, 2023
- Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1Esophagus, 2023
- Clinical significance of sarcopenic dysphagia for patients with esophageal cancer undergoing esophagectomy: A reviewAnnals of Gastroenterological Surgery, 2022
- Risk factors and long‐term postoperative outcomes in patients with postoperative dysphagia after esophagectomy for esophageal cancerAnnals of Gastroenterological Surgery, 2022
- Postoperative recurrent laryngeal nerve palsy is associated with pneumonia in minimally invasive esophagectomy for esophageal cancerSurgical Endoscopy, 2020
- Minimally invasive esophagectomy and radical lymph node dissection without recurrent laryngeal nerve paralysisSurgical Endoscopy, 2020
- Meta-analysis of the impact of postoperative complications on survival after oesophagectomy for cancerBJS Open, 2018